Provista Diagnostics (PDx) Expands its Contract Research Offerings Through its Provista Dx Reference Laboratory  
1/10/2013 9:27:55 AM

Scottsdale, Arizona, Jan. 9, 2013 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a leading molecular diagnostics company, is pleased to announce the addition of new contract research services and technologies to be offered to the pharmaceutical and biotechnology industries by its Provista Dx Reference Laboratory. These new services, combined with the company's existing complement of development and testing services, allow Provista to offer its customers a complete solution to their laboratory needs, including consultation, assay evaluation and development, method development, clinical laboratory services, clinical trial design and diagnostic support, analytical regulatory guidance and companion diagnostics. Furthermore, the Provista Dx Reference Laboratory offers a comprehensive array of technologies, such as qualitative and quantitative immunohistochemistry, advanced protein analysis (ELISA, Luminex and MSD) and next generation sequencing (Real Time qPCR, Ion Torrent).